Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
St Shine Optical CoROCO:1565 -1.12%74 EV-to-EBITDA is 3.93 as of Sep. 12, 2026, which is 58% below its 10-year median of 9.35. GuruFocus rates ROCO:1565 with a GF Score™ of 74/100 and a GF Value™ of NT$148.96 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 516 Medical Devices & Instruments companies, St Shine Optical Co ranks better than 91.47% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, St Shine Optical Co's enterprise value is NT$2,934 Mil.
St Shine Optical Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$747 Mil. Therefore, St Shine Optical Co's EV-to-EBITDA for today is 3.93.
The historical rank and industry rank for St Shine Optical Co's EV-to-EBITDA or its related term are showing as below:
ROCO:1565'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.63 Med: 9.35 Max: 21.64
Current: 3.93
During the past 13 years, the highest EV-to-EBITDA of St Shine Optical Co was 21.64. The lowest was 3.63. And the median was 9.35.
ROCO:1565's EV-to-EBITDA is ranked better than 91.47% of 516
companies
in the Medical Devices & Instruments industry
Industry Median: 13.675
vs ROCO:1565: 3.93
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
St Shine Optical Co (ROCO:1565) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
St Shine Optical Co's PE Ratio (TTM) for today is calculated as:
St Shine Optical Co's share price for today is NT$97.10.
St Shine Optical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$7.930.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for St Shine Optical Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:1565 vs ISRG, BDX, RMD: EV-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, St Shine Optical Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
St Shine Optical Co EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, St Shine Optical Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where St Shine Optical Co's EV-to-EBITDA falls into.
St Shine Optical Co's current Enterprise Value is NT$2,934 Mil.
St Shine Optical Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$747 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
St Shine Optical Co (ROCO:1565) has a EV-to-EBITDA of 3.93 as of Sep. 12, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on St Shine Optical Co. This is 58% below median its historical median of 9.35. Over the past decade, St Shine Optical Co's EV-to-EBITDA has ranged from 3.63 to 21.64. According to the industry distribution chart, St Shine Optical Co ranks #44 out of 516 companies in the Medical Devices & Instruments industry, placing it in the top 8.5%.
Is St Shine Optical Co's EV-to-EBITDA too high?
St Shine Optical Co's current EV-to-EBITDA of 3.93 is 58% below median its 10-year median of 9.35. Over the past 10 years, this metric has ranged from a low of 3.63 to a high of 21.64. The Medical Devices & Instruments industry median EV-to-EBITDA is 13.68. St Shine Optical Co's value of 3.93 is 71.3% below this industry median. Based on the distribution chart, St Shine Optical Co ranks #44 out of 516 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, St Shine Optical Co has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does St Shine Optical Co's EV-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, St Shine Optical Co ranks #44 out of 516 companies for EV-to-EBITDA. This places St Shine Optical Co in the top 9% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 13.68. St Shine Optical Co's value of 3.93 is 71.3% below this benchmark. Historically, St Shine Optical Co's own EV-to-EBITDA has ranged from 3.63 to 21.64 over the past decade. While the company's 10-year median is 9.35 vs. the industry median of 13.68, St Shine Optical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 13.68, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. St Shine Optical Co's current EV-to-EBITDA of 3.93 is 71.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on St Shine Optical Co. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 13.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. St Shine Optical Co's current EV-to-EBITDA is 3.93, which is 58% below median its own 10-year median of 9.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is St Shine Optical Co stock overvalued right now?
Based on GuruFocus' analysis, St Shine Optical Co (ROCO:1565) is currently considered Possible Value Trap. The stock's GF Value™ is NT$148.96, compared to a current price of NT$97.10 — trading 34.8% below its estimated fair value. The current EV-to-EBITDA is 3.93, which is 58% below median its 10-year median of 9.35 and 71.3% below the Medical Devices & Instruments industry median of 13.68. St Shine Optical Co's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For St Shine Optical Co (ROCO:1565), the current EV-to-EBITDA is 3.93 as of Sep. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is St Shine Optical Co (ROCO:1565) Overvalued in 2026?
Based on GuruFocus' analysis, St Shine Optical Co stock appears to be undervalued.
The current stock price of NT$97.10 is trading 34.8% below its estimated GF Value™ of NT$148.96.
GuruFocus considers St Shine Optical Co to be Possible Value Trap.
Key valuation signals for ROCO:1565:
EV-to-EBITDA: 3.93 (58% below median its 10-year median of 9.35)
GF Value™: NT$148.96 vs. price of NT$97.10 (34.8% below fair value)
Industry Position: 71.3% below the Medical Devices & Instruments median (#44 of 516)
No single metric tells the full story. See the ROCO:1565 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
St Shine Optical Co Ltd is engaged in the manufacturing and trading of contact lenses (soft and hard), optical lenses, and related products. Geographically, the company generates maximum of its revenue from Asia (excluding Taiwan), followed by Europe, Taiwan, and America.
74GF Score
Get the complete analysis for ROCO:1565
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1565 has been successfully added to your 
